» Articles » PMID: 32705279

Detection and Analysis of Angiogenesis Pathway‑associated LncRNA Expression Profiles in Human Skin Fibroblasts Under High‑glucose Conditions

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2020 Jul 25
PMID 32705279
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence has indicated that long non‑coding RNAs (lncRNAs) have crucial roles in wound healing and that vascular lesions in diabetic wounds are frequently difficult to heal. However, the role of angiogenesis pathway‑associated lncRNAs in wound healing in diabetic patients has remained to be fully elucidated. In the present study, human skin fibroblasts were cultured under high‑glucose conditions in vitro to mimic a diabetic environment and the angiogenesis pathway‑associated lncRNA expression profile in the high‑ and normal‑glucose groups was examined. The microarray data indicated that 14 lncRNAs and 22 mRNAs were differentially expressed. Several candidate lncRNAs and mRNAs were then analyzed by reverse transcription‑quantitative PCR and the results were consistent with the microarray data. Furthermore, the University of California Santa Cruz Genome Browser was used to identify mRNAs linked to angiogenesis pathways near the transcriptional region of lncRNAs. The results suggested that lncRNAs RP4‑791C19.1 and CTD‑2589O24.1 may act on their target genes epidermal growth factor receptor and p21 (RAC1) activated kinase 1, respectively, as enhancers and cis‑regulate their expression. Therefore, the present study confirmed that several angiogenesis pathway‑associated lncRNAs were differentially expressed under high‑glucose conditions, which may have a key role in wound healing in patients with diabetes.

Citing Articles

LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p.

Yang M, Gu Y Ir J Med Sci. 2023; 193(1):241-247.

PMID: 37515685 DOI: 10.1007/s11845-023-03471-x.


Thermosensitive and antioxidant wound dressings capable of adaptively regulating TGFβ pathways promote diabetic wound healing.

Niu H, Guan Y, Zhong T, Ma L, Zayed M, Guan J NPJ Regen Med. 2023; 8(1):32.

PMID: 37422462 PMC: 10329719. DOI: 10.1038/s41536-023-00313-3.


Long non-coding RNAs in diabetic wound healing: Current research and clinical relevance.

Kuai L, Jiang J, Li W, Li B, Yin S Int Wound J. 2021; 19(3):583-600.

PMID: 34337861 PMC: 8874090. DOI: 10.1111/iwj.13655.


Emerging Roles of Long Non-Coding RNAs in Diabetic Foot Ulcers.

Yan C, Chen J, Yang X, Li W, Mao R, Chen Z Diabetes Metab Syndr Obes. 2021; 14:2549-2560.

PMID: 34135607 PMC: 8200159. DOI: 10.2147/DMSO.S310566.


The progress, prospects, and challenges of the use of non-coding RNA for diabetic wounds.

Li J, Wei M, Liu X, Xiao S, Cai Y, Li F Mol Ther Nucleic Acids. 2021; 24:554-578.

PMID: 33981479 PMC: 8063712. DOI: 10.1016/j.omtn.2021.03.015.

References
1.
Hu C, Jia W . Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication. Diabetes. 2017; 67(1):3-11. DOI: 10.2337/dbi17-0013. View

2.
Pennacchio L, Bickmore W, Dean A, Nobrega M, Bejerano G . Enhancers: five essential questions. Nat Rev Genet. 2013; 14(4):288-95. PMC: 4445073. DOI: 10.1038/nrg3458. View

3.
Wu Y, Yuan M, Su W, Zhu M, Yao X, Wang Y . The constitutively active PKG II mutant effectively inhibits gastric cancer development a blockade of EGF/EGFR-associated signalling cascades. Ther Adv Med Oncol. 2018; 10:1758834017751635. PMC: 5802699. DOI: 10.1177/1758834017751635. View

4.
Nambiar D, Kujur P, Singh R . Angiogenesis Assays. Methods Mol Biol. 2015; 1379:107-15. DOI: 10.1007/978-1-4939-3191-0_10. View

5.
Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View